The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and now they're doing all these clinical trials with the selective serotonin antagonist called turbo right what this drug does is basically similar to bromocryptin it's an Agonist of several dopamine receptors but it's also an antagonist uh on several serotonin receptors but most strongly the 5hd2b
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.